RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dae Hwa Pharm Co - Stock

Dae Hwa Pharm Co P/E 2024

Dae Hwa Pharm Co P/E

-149.84

Ticker

067080.KQ

ISIN

KR7067080002

As of Jul 8, 2024, Dae Hwa Pharm Co's P/E ratio was -149.84, a -217.25% change from the 127.8 P/E ratio recorded in the previous year.

The Dae Hwa Pharm Co P/E history

Dae Hwa Pharm Co Aktienanalyse

What does Dae Hwa Pharm Co do?

Dae Hwa Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Dae Hwa Pharm Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Dae Hwa Pharm Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Dae Hwa Pharm Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Dae Hwa Pharm Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Dae Hwa Pharm Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Dae Hwa Pharm Co stock

What is the price-to-earnings ratio of Dae Hwa Pharm Co?

The price-earnings ratio of Dae Hwa Pharm Co is currently -149.84.

How has the price-earnings ratio of Dae Hwa Pharm Co changed compared to last year?

The price-to-earnings ratio of Dae Hwa Pharm Co has increased by -217.25% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Dae Hwa Pharm Co high compared to other companies?

Yes, the price-to-earnings ratio of Dae Hwa Pharm Co is high compared to other companies.

How does an increase in the price-earnings ratio of Dae Hwa Pharm Co affect the company?

An increase in the price-earnings ratio of Dae Hwa Pharm Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Dae Hwa Pharm Co affect the company?

A decrease in the price-earnings ratio of Dae Hwa Pharm Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Dae Hwa Pharm Co?

Some factors that influence the price-earnings ratio of Dae Hwa Pharm Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Dae Hwa Pharm Co pay?

Over the past 12 months, Dae Hwa Pharm Co paid a dividend of 150 KRW . This corresponds to a dividend yield of about 1.37 %. For the coming 12 months, Dae Hwa Pharm Co is expected to pay a dividend of 150 KRW.

What is the dividend yield of Dae Hwa Pharm Co?

The current dividend yield of Dae Hwa Pharm Co is 1.37 %.

When does Dae Hwa Pharm Co pay dividends?

Dae Hwa Pharm Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.

How secure is the dividend of Dae Hwa Pharm Co?

Dae Hwa Pharm Co paid dividends every year for the past 20 years.

What is the dividend of Dae Hwa Pharm Co?

For the upcoming 12 months, dividends amounting to 150 KRW are expected. This corresponds to a dividend yield of 1.37 %.

In which sector is Dae Hwa Pharm Co located?

Dae Hwa Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dae Hwa Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dae Hwa Pharm Co from 5/1/2024 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Dae Hwa Pharm Co pay the last dividend?

The last dividend was paid out on 5/1/2024.

What was the dividend of Dae Hwa Pharm Co in the year 2023?

In the year 2023, Dae Hwa Pharm Co distributed 150 KRW as dividends.

In which currency does Dae Hwa Pharm Co pay out the dividend?

The dividends of Dae Hwa Pharm Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dae Hwa Pharm Co

Our stock analysis for Dae Hwa Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dae Hwa Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.